2. Others

Others

Others

Related Products

PDF 58.49 MB

There are a number of inhibitors, agonists, and antagonists which we cannot make precise classification because the research area is still unknown.

Others Related Products (73764):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-171618
    Morpholino U subunit 2388517-98-2
    Morpholino U subunit is one of the basic units that make up morpholino oligonucleotides. Morpholino U subunit can pair with adenine in the target RNA.
    Morpholino U subunit
  • HY-171631
    5'-O-DMTr-Nap-dU-3'-CE Phosphoramidite 2133842-85-8
    5'-O-DMTr-Nap-dU-3'-CE Phosphoramidite is a phosphoramidite monomer used in nucleic acid synthesis, such as oligonucleotides.
    5'-O-DMTr-Nap-dU-3'-CE Phosphoramidite
  • HY-171632
    2'-(2-Nitrobenzyl)-ATP 870997-99-2 98%
    2'-(2-Nitrobenzyl)-ATP is an rATP analog. 2'-(2-Nitrobenzyl)-ATP acts as a transcription terminator, inhibiting further RNA chain elongation by T7 RNA polymerase.
    2'-(2-Nitrobenzyl)-ATP
  • HY-171703
    2'-Amino Cytidine CED phosphoramidite 176755-95-6
    2'-Amino Cytidine CED phosphoramidite is a phosphoramidite that can be used in the synthesis of oligonucleotides.
    2'-Amino Cytidine CED phosphoramidite
  • HY-171704
    3'-O-DMT-α-L-threofuranosyl-G(iBu)-2'-CE-phosphoramidite
    3'-O-DMT-α-L-threofuranosyl-G(iBu)-2'-CE-phosphoramidite is a phosphoramidite that can be used in the synthesis of oligonucleotides.
    3'-O-DMT-α-L-threofuranosyl-G(iBu)-2'-CE-phosphoramidite
  • HY-171720
    Ascr#12 1355681-43-4 98%
    Ascr#12 (Asc-C6) is an ascaroside derivative that exhibits extremely low activity in inducing the dauer (dormant larval) stage. Ascr#12 enhances the reproductive capacity of the invasive pine wood nematode.
    Ascr#12
  • HY-171721
    Ascr#14 1355681-47-8 98%
    Ascr#14 (Asc-C8) is an ascaroside derivative that exhibits low activity in inducing the dauer (dormant larval) stage.
    Ascr#14
  • HY-171739
    PLPEth (16:0/18:2 PEth) 336786-73-3
    PLPEth (16:0/18:2 PEth) is a predominant phosphatidylethanol homologue and can be used as direct biomarker for long-term alcohol use.
    PLPEth (16:0/18:2 PEth)
  • HY-171764
    β-Ethoxy-α-ketobutyraldehyde 3688-37-7
    β-Ethoxy-α-ketobutyraldehyde is a chemical probe. β-Ethoxy-α-ketobutyraldehyde specifically modifies the N1 and N2 positions of guanine. β-Ethoxy-α-ketobutyraldehyde is mainly used to study the steric protection of single-stranded/double-stranded regions of nucleic acids and protein binding sites. β-Ethoxy-α-ketobutyraldehyde can be used for nucleic acid structure analysis and footprint studies of protein-nucleic acid complexes.
    β-Ethoxy-α-ketobutyraldehyde
  • HY-171853
    RWJ-68022 223442-22-6
    RWJ-68022 (Example 9) is a cyclopentene derivative and a motilin receptor antagonist. RWJ-68022 can compete with motilin and erythromycin for the motilin receptor site. RWJ-68022 can be used in the research of gastrointestinal-related diseases.
    RWJ-68022
  • HY-171901
    (R)-(-)-Linoleyl-2'-hydroxy-1'-propylamide
    (R)-(-)-Linoleyl-2'-hydroxy-1'-propylamide is a LOEA homolog, which can be characterized by the addition of an (R)-β-methyl group at the terminal ethanolamine carbon.
    (R)-(-)-Linoleyl-2'-hydroxy-1'-propylamide
  • HY-171902
    (R)-(-)-Docosahexaenyl-2'-hydroxy-1'-propylamide
    (R)-(-)-Docosahexaenyl-2'-hydroxy-1'-propylamide is a DHEA homolog. (R)-(-)-Docosahexaenyl-2'-hydroxy-1'-propylamide is characterized by the addition of an (R)-β-methyl group at the terminal ethanolamine carbon.
    (R)-(-)-Docosahexaenyl-2'-hydroxy-1'-propylamide
  • HY-171904
    BCP-NC2-C12 98%
    BCP-NC2-C12 is an ionizable cationic lipid. BCP-NC2-C12 can be used to generate lipid nanoparticles (LNPs) for in vivo delivery of mRNA. BCP-NC2-C12 LNPs mediated an approximately 90% reduction in PCSK9 serum protein levels via CRISPR/Cas9 gene knockout.
    BCP-NC2-C12
  • HY-171938
    5-Aza-N6-benzoyl-5'-O-DMT-2'-deoxycytidine 3'-CE phosphoramidite 929904-98-3
    5-Aza-N6-benzoyl-5'-O-DMT-2'-deoxycytidine 3'-CE phosphoramidite is a phosphoramidite that can be used in the synthesis of oligonucleotides.
    5-Aza-N6-benzoyl-5'-O-DMT-2'-deoxycytidine 3'-CE phosphoramidite
  • HY-171944
    6-O-Oleoyltrehalose 338733-38-3
    6-O-Oleoyltrehalose is a derivative of trehalose. 6-O-Oleoyltrehalose has biodegradable and low surface tension reduction ability. 6-O-Oleoyltrehalose preserves Lactate dehydrogenase (LDH) activity during freeze/thaw cycles. 6-O-Oleoyltrehalose can be used for stabilizer research.
    6-O-Oleoyltrehalose
  • HY-171951
    31hP
    31hP is an asymmetric A3 lipid. 31hP can facilitate in vivo luciferase expression. 31hP can be rapidly degraded in the presence of esterase owing to two biocleavable ester bonds. 31hP can be used in the synthesis of lipid nanoparticles (LNPs).
    31hP
  • HY-171953
    THP1 Lipid 3097638-13-3 98%
    THP1 Lipid is an ionizable lipidoid. THP1 Lipid can be used to synthesize lipid nanoparticles (LNPs) for delivering mRNA to muscles with minimal toxicity and editing genes in specific liver tissues in tdTomato transgenic mice model. THP1 Lipid can be used for vaccine delivery and CRISPR/Cas9-mediated gene editing research.
    THP1 Lipid
  • HY-171982
    ATII 68857-95-4
    ATII (Traseolide), a Polycyclic musk fragrance, is a hydrophobic hapten. ATII has no genotoxicity in the human lymphocytes and the human hepatoma cell line Hep G2. ATII can be bound by antibody M02/05/01 (H93 Val) with superior binding capacity. ATII can be conjugated to carrier proteins for antigen design.
    ATII
  • HY-171985
    DCPD 4175-38-6
    DCPD is an amine substance with both embryotoxicity and teratogenicity, and its total effect ED50 is 0.6 μmol per egg. DCPD induces early and late embryonic death, and causes multiple embryonic malformations including microcephaly, hypoplastic optic cup, eyelid and corneal defects. DCPD can serve as a calcium phosphate additive for biomimetic α-tricalcium phosphate bone cement, which inhibits the transformation of α-tricalcium phosphate into calcium-deficient hydroxyapatite, blocks the release of Gelatins (HY-Y1365), and effectively prolongs the setting time of bone cement. DCPD is applicable to studies related to embryonic malformations.\n
    DCPD
  • HY-171987
    trans-4-Hydroxyprolinol-C10-tri-GalNAc 1469730-77-5
    trans-4-Hydroxyprolinol-C10-tri-GalNAc (Formula XXIV) is a Tri-GaINAc derivative that can be used for nucleic acid drug coupling.
    trans-4-Hydroxyprolinol-C10-tri-GalNAc